Rare diseases
Investigational molecules
Locations
Ul. Zbożowa 2/25, 30-002 Cracow, Poland
Specjalistyczny gabinet dermatologiczny Aplikacyjno-Badawczy M. Brzewski, P. Brzewski S.C. in Cracow, Poland specialises in clinical trials of conditions such as Dermatitis atopic, Alopecia areata, Psoriasis, Hidradenitis, and other specialisations. This site conducts important research.
The medical center is at the forefront of oncology research, focusing on innovative treatments for breast cancer. The center's commitment to advancing cancer care is evident through its exploration of therapies that address the unique challenges faced by women undergoing hormone therapy.
By integrating cutting-edge research with clinical practice, the center enhances the quality of life for patients, offering hope and improved outcomes through personalized treatment strategies.
Specializing in women's health, the center is dedicated to addressing the complex needs of women experiencing vasomotor symptoms due to cancer treatments. This focus ensures that women receive comprehensive care that considers both their physical and emotional well-being.
The center's research initiatives aim to develop therapies that not only alleviate symptoms but also empower women to lead fulfilling lives during and after treatment.
In the realm of pharmacology, the center is pioneering the development of novel medications that target moderate to severe vasomotor symptoms. This research is crucial for creating effective, safe, and targeted therapies that improve patient outcomes.
Through rigorous clinical trials and collaborations with leading pharmaceutical companies, the center is shaping the future of medication for symptom management in cancer care.
Clinical trials currently enrolling participants at this site.
A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
PolandPharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis
PolandA study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies
PolandLong-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031
PolandStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
PolandEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
PolandStudy on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
PolandStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
PolandStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
PolandPolandA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
PolandStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
